Nihon Kohden Corporation Grabs Defibtech for Undisclosed Amount
Published: Nov 14, 2012
A significant expansion of technologies and capabilities
The integration of the two companies will create a strengthened force in the global AED market. Defibtech and Nihon Kohden have placed more than 360,000 AEDs throughout the world and expect that number to increase significantly. Defibtech plans to add to its reputation as an innovative and growing company in the AED market. In addition, Defibtech intends to accelerate its development of products targeting a number of other resuscitation markets.
“Defibtech will not only continue expanding its AED product lineup, but also plans to develop and market other resuscitation solutions,” said Defibtech CEO Dr. Glenn W. Laub. “Over the past decade, having deployed more than 160,000 AEDs worldwide, we are a steadily growing force in the resuscitation market. We want to continue that growth.” Recognized as outstanding by safety experts, industrial design organizations and loyal customers, Defibtech AEDs are marked by superior engineering and usability, innovative design, and affordable pricing. “Our new resuscitation solutions will have the same high level of value and quality,” Dr. Laub stated.
Defibtech will continue to operate independently as a wholly owned subsidiary of Delaware-based Resuscitation Solution Inc., a U.S. subsidiary of Nihon Kohden, said Gintaras Vaisnys, Defibtech President. “This is a great opportunity for Defibtech and Nihon Kohden to complement their strengths,” he stated. Defibtech’s innovative business model will be further enhanced by the global strength of Nihon Kohden, a leading force in the medical device field. “We are excited about a number of new product development and market opportunities that may result from this relationship, which will help Defibtech grow aggressively in the coming years,” said Vaisnys. Defibtech’s products will continue to bear the highly respected Defibtech name and be designed, manufactured and supported by Defibtech personnel.
Expansion of business in the U.S. market
For Nihon Kohden, expanding its business in the U.S. market is a strategic goal. Currently, Nihon Kohden operates in the U.S. primarily through its neurology and patient monitoring businesses. Through the acquisition of Defibtech, Nihon Kohden will enter the U.S. resuscitation market, the largest in the world.
The U.S. is also a center of pioneering research in resuscitation science, and the resulting knowledge strongly influences worldwide trends in this field. Nihon Kohden’s acquisition of Defibtech establishes a U.S. development base for resuscitation solutions, enabling the integrated organizations to identify market trends in early stages, strengthen collaboration with leading research and development institutes, and develop innovative resuscitation technology for sale throughout the world.
Defibtech, LLC, relentlessly pursues one goal: making the best AEDs in the world at affordable prices. Defibtech designs and manufactures defibrillators, which include the Lifeline™ and ReviveR™ families of AEDs. Defibtech’s products are sold through its network of distribution partners in the United States and around the world. Defibtech is headquartered in Guilford, Conn. All Defibtech AEDs are manufactured in the United States in state-of-the-art ISO 13485:2003 certified facilities. For more information about Defibtech and its products, visit www.defibtech.com or call +1-203-453-4507.
About Nihon Kohden
Nihon Kohden is Japan's leading manufacturer and provider of electronic medical equipment. With annual sales topping $1.5 billion, Nihon Kohden is one of the top 100 medical device companies in the world. Nihon Kohden is a publicly held company listed on the Tokyo Stock Exchange. For more information about Nihon Kohden, go to www.nihonkohden.com.
Ray Valek, 708-352-8695